INTERCEPT PHARMACEUTICALS, INC.·4

Jan 3, 7:00 PM ET

Sullivan Ryan T 4

4 · INTERCEPT PHARMACEUTICALS, INC. · Filed Jan 3, 2020

Insider Transaction Report

Form 4
Period: 2019-12-31
Sullivan Ryan T
General Counsel
Transactions
  • Tax Payment

    Common Stock

    2019-12-31$123.92/sh809$100,25121,080 total
Footnotes (1)
  • [F1]Represents shares of common stock withheld by the Issuer to satisfy taxes associated with the partial vesting of a restricted stock unit award previously granted to the reporting person.

Documents

1 file
  • 4
    tm201209d10_4.xmlPrimary

    OWNERSHIP DOCUMENT